Skip to content

DC Medic: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

DC Medic

BE 0787.363.549
NACE 86.210, General medical practice
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€109,803
2024 · €158,002-€48,199
Equity
€138,584
2024 · €328,781-€190,197
Cash
€141,196
2024 · €300,606-€159,410
Balance sheet total
€449,099
2024 · €350,027+€99,071

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€269,037

    up €269,037 (+6385.4%), from €4,213 to €273,250

    of which Other amounts receivable: +€265,787

  • Cash -€159,410

    down €159,410 (-53.0%), from €300,606 to €141,196

    mainly Contributions, distributions and other (-€300,000) and Receivables within one year (-€269,037)

  • Tangible fixed assets -€10,705

    down €10,705 (-27.2%), from €39,322 to €28,618

    of which Furniture and vehicles: -€7,246

Equity and liabilities
  • Other debts +€300,000

    new in 2025: €300,000

  • Profit (loss) carried forward -€190,197

    down €190,197 (-58.5%), from €325,281 to €135,084

  • Debts after one year -€7,089

    down €7,089 (-74.6%), from €9,505 to €2,416

Income statement
  • Gross operating margin -€64,224

    down €64,224 (-28.9%), from €222,524 to €158,300

  • Taxes -€15,222

    down €15,222 (-31.9%), from €47,700 to €32,478

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €158,002
Gross operating margin -€64,224
Depreciation +€380
Other operating charges -€257
Financial income -€0
Financial charges +€680
Taxes +€15,222
Result 2025 €109,803

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€150,784
Investment -€3,336
Financing -€306,858
Cash 2024 €300,606
Net result for the year +€109,803
Depreciation +€14,041
Receivables within one year -€269,037
Deferred charges and accrued income -€149
Trade debts -€3,874
Other debts +€300,000
Investment in fixed assets (net) -€3,336
Debts after one year -€7,089
Current portion of long-term debt +€231
Contributions, distributions and other -€300,000
Cash 2025 €141,196
Every line side by side 35 lines
Line Code 2024 2025 Change %
Total assets 20/58 €350,027 €449,099 +€99,071 +28.3%
Fixed assets 21/28 €39,322 €28,618 -€10,705 -27.2%
Tangible fixed assets 22/27 €39,322 €28,618 -€10,705 -27.2%
Plant, machinery and equipment 23 €16,544 €13,086 -€3,458 -20.9%
Furniture and vehicles 24 €22,778 €15,532 -€7,246 -31.8%
Current assets 29/58 €310,705 €420,481 +€109,776 +35.3%
Amounts receivable within one year 40/41 €4,213 €273,250 +€269,037 +6385.4%
Trade receivables 40 €650 €3,900 +€3,250 +500.0%
Other amounts receivable 41 €3,563 €269,350 +€265,787 +7459.1%
Cash at bank and in hand 54/58 €300,606 €141,196 -€159,410 -53.0%
Deferred charges and accrued income 490/1 €5,886 €6,035 +€149 +2.5%
Total equity and liabilities 10/49 €350,027 €449,099 +€99,071 +28.3%
Equity 10/15 €328,781 €138,584 -€190,197 -57.8%
Contributions 10/11 €3,500 €3,500 = 0.0%
Profit (loss) carried forward 14 €325,281 €135,084 -€190,197 -58.5%
Amounts payable 17/49 €21,246 €310,515 +€289,268 +1361.5%
Amounts payable after more than one year 17 €9,505 €2,416 -€7,089 -74.6%
Financial debts 170/4 €9,505 €2,416 -€7,089 -74.6%
Amounts payable within one year 42/48 €11,741 €308,099 +€296,358 +2524.0%
Current portion of amounts payable after more than one year 42 €6,858 €7,089 +€231 +3.4%
Trade debts 44 €4,883 €1,010 -€3,874 -79.3%
Suppliers 440/4 €4,883 €1,010 -€3,874 -79.3%
Other amounts payable 47/48 - €300,000 +€300,000
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €14,421 €14,041 -€380 -2.6%
Other operating charges 640/8 €494 €751 +€257 +52.1%
Gross operating margin 9900 €222,524 €158,300 -€64,224 -28.9%
Operating profit (loss) 9901 €207,609 €143,508 -€64,101 -30.9%
Financial income 75/76B €0 €0 -€0 -94.7%
Recurring financial income 75 €0 €0 -€0 -94.7%
Financial charges 65/66B €1,908 €1,228 -€680 -35.7%
Recurring financial charges 65 €1,908 €1,228 -€680 -35.7%
Profit (loss) for the period before taxes 9903 €205,702 €142,281 -€63,421 -30.8%
Income taxes 67/77 €47,700 €32,478 -€15,222 -31.9%
Profit (loss) for the period 9904 €158,002 €109,803 -€48,199 -30.5%
Profit (loss) for the period to be appropriated 9905 €158,002 €109,803 -€48,199 -30.5%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.